Gene · 5378
Papers1,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis. | Int J Mol Sci | 2022 | 35563301 | PubTator, text mining | PubMed |
| Establishment and Application of a Prognostic Risk Score Model Based on Characteristics of Different Immunophenotypes for Lung Adenocarcinoma. | Front Genet | 2022 | 35547263 | PubTator, text mining | PubMed |
| The role of DNA mismatch repair in immunotherapy of human cancer. | Int J Biol Sci | 2022 | 35541922 | PubTator, text mining | PubMed |
| An evolutionary explanation for antibiotics' association with increased colon cancer risk. | Evol Med Public Health | 2022 | 35539898 | PubTator, text mining | PubMed |
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
| Adrenal pheochromocytoma in a patient with Lynch Syndrome. | Urol Case Rep | 2022 | 35530545 | PubTator, text mining | PubMed |
| Recent advances in understanding pancreatic cancer. | Fac Rev | 2022 | 35509672 | PubTator, text mining | PubMed |
| DNA repair and damage pathways in mesothelioma development and therapy. | Cancer Cell Int | 2022 | 35501851 | PubTator, text mining | PubMed |
| Classification of lung adenocarcinoma based on stemness scores in bulk and single cell transcriptomes. | Comput Struct Biotechnol J | 2022 | 35495113 | PubTator, text mining | PubMed |
| In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps. | PLoS One | 2022 | 35486660 | PubTator, text mining | PubMed |
| Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group. | Front Oncol | 2022 | 35463299 | PubTator, text mining | PubMed |
| Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). | Cancers (Basel) | 2022 | 35454934 | PubTator, text mining | PubMed |
| The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in the pathogenesis of osteosarcoma. | Transl Oncol | 2022 | 35452995 | PubTator, text mining | PubMed |
| Predictive functional assay-based classification of PMS2 variants in Lynch syndrome. | Hum Mutat | 2022 | 35451539 | PubTator, text mining | PubMed |
| A Novel Quantification System Combining iTRAQ Technology and Multi-Omics Assessment to Predict Prognosis and Immunotherapy Efficacy in Colon Cancer. | Front Bioeng Biotechnol | 2022 | 35445008 | PubTator, text mining | PubMed |
| Polyglutamine Expansion in Huntingtin and Mechanism of DNA Damage Repair Defects in Huntington's Disease. | Front Cell Neurosci | 2022 | 35444517 | PubTator, text mining | PubMed |
| Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR/MSI-H gastric adenocarcinoma. | BMC Med | 2022 | 35443723 | PubTator, text mining | PubMed |
| Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases. | Hum Mol Genet | 2022 | 35441217 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5378/papers?page=18